|
|
|
< Previous page
|
|
|
| Related Keyword：京東 , 一手中簽率 , 超購 , 新股 , 沛嘉 , 建業新生活 |
| Related Concept：萬人認購京東一手中簽率 , 香港公開發售 , 建業新生活超購逾 , 沛嘉醫療公開發售 |
| |
| 【新股IPO】9618京東超購近178倍1手中簽率10%（附分配結果） - 香港經濟日報- 即時新聞頻道- 金融經濟 ＠ 2020-06-17T16: |
| 京東（09618）公布招股結果，京東一如早前公布，以每股226元定價，集資淨額297.7億元。京東1手中簽率為10%，抽40手（2000股）可穩獲1手。【分配結果】 京東公開 ... |
| Keyword：京東 一手中簽率 |
| Concept：萬人認購京東一手中簽率 , 香港公開發售 |
| 《新股消息》沛嘉醫療(09996.HK)超購1,183倍成今年凍資王一手中簽率僅8.5% ＠ 2020-05-15T04: |
| 內地介入手術醫療器械生產商沛嘉醫療(09996.HK)公布招股結果，公開發售錄得超額認購逾1183.41倍，凍資約2800億元，成為今年凍資王。啟動重新分配及回撥後， ... |
| Keyword：超購 新股 沛嘉 建業新生活 |
| Concept：建業新生活超購逾 , 沛嘉醫療公開發售 |
|
|
< Previous page
|
|
|
|
|
| Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.
|
|
